Tag: Rajeev Nannapaneni
-
US Tax Policy Impact on India Pharma Sector: Exclusive Interview
US Tax Policy: A New Challenge for India’s Pharma Scene Recent discussions around US tax policy have put the Indian pharmaceutical sector in the spotlight. Reports indicate that about 92% of medicines manufactured in India are consumed by the American market, underscoring how closely tied India’s pharma industry is to the United States. In this…
-
Exclusive Interview: US Tax Policy Impact on Indian Pharma
Overview: US Tax Policy and Indian Pharma The Trump administration’s second term has been marked by a push toward protectionist tax measures, tariffs, and tighter control on foreign-based operations. In this context, India’s booming pharmaceutical industry—an ecosystem where the United States represents a major, sometimes dominant market—faces questions about how new fiscal rules might reshape…